Rank | Gene Set | Z-score |
---|---|---|
1 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.83650452 |
2 | urate metabolic process (GO:0046415) | 6.36747109 |
3 | desmosome organization (GO:0002934) | 6.22421642 |
4 | drug transmembrane transport (GO:0006855) | 5.80491322 |
5 | ribosomal small subunit assembly (GO:0000028) | 5.73566624 |
6 | phospholipid scrambling (GO:0017121) | 5.45843433 |
7 | organic cation transport (GO:0015695) | 5.26343420 |
8 | drug transport (GO:0015893) | 5.18529756 |
9 | establishment of skin barrier (GO:0061436) | 4.86580057 |
10 | viral transcription (GO:0019083) | 4.82496207 |
11 | neutrophil activation involved in immune response (GO:0002283) | 4.70624402 |
12 | translational termination (GO:0006415) | 4.56587276 |
13 | regulation of water loss via skin (GO:0033561) | 4.38729670 |
14 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.38565878 |
15 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.34056046 |
16 | toxin transport (GO:1901998) | 4.24995391 |
17 | glycoside metabolic process (GO:0016137) | 4.24861079 |
18 | definitive hemopoiesis (GO:0060216) | 4.15317984 |
19 | sphingoid metabolic process (GO:0046519) | 4.10077589 |
20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.06615996 |
21 | protein targeting to ER (GO:0045047) | 4.02117012 |
22 | cotranslational protein targeting to membrane (GO:0006613) | 3.97037927 |
23 | excretion (GO:0007588) | 3.95234110 |
24 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.94171646 |
25 | response to mercury ion (GO:0046689) | 3.89587592 |
26 | thrombin receptor signaling pathway (GO:0070493) | 3.86026049 |
27 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.85177654 |
28 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.84900771 |
29 | valine metabolic process (GO:0006573) | 3.84517957 |
30 | protein localization to endoplasmic reticulum (GO:0070972) | 3.81074428 |
31 | ribosomal small subunit biogenesis (GO:0042274) | 3.80302012 |
32 | translational elongation (GO:0006414) | 3.76594963 |
33 | protein neddylation (GO:0045116) | 3.70675077 |
34 | regulation of natural killer cell differentiation (GO:0032823) | 3.69024311 |
35 | platelet dense granule organization (GO:0060155) | 3.67396247 |
36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.66268906 |
37 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.66268906 |
38 | detection of bacterium (GO:0016045) | 3.65758741 |
39 | keratinization (GO:0031424) | 3.64199288 |
40 | tricarboxylic acid metabolic process (GO:0072350) | 3.64034336 |
41 | blood coagulation, intrinsic pathway (GO:0007597) | 3.62839430 |
42 | multicellular organismal water homeostasis (GO:0050891) | 3.62266200 |
43 | viral life cycle (GO:0019058) | 3.61573165 |
44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.61557116 |
45 | L-phenylalanine metabolic process (GO:0006558) | 3.61557116 |
46 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.58108470 |
47 | quaternary ammonium group transport (GO:0015697) | 3.57228626 |
48 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.56366957 |
49 | phosphate ion homeostasis (GO:0055062) | 3.54541318 |
50 | trivalent inorganic anion homeostasis (GO:0072506) | 3.54541318 |
51 | peptide catabolic process (GO:0043171) | 3.54228562 |
52 | phosphate ion transport (GO:0006817) | 3.49926877 |
53 | keratinocyte proliferation (GO:0043616) | 3.49540419 |
54 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.47266979 |
55 | L-phenylalanine catabolic process (GO:0006559) | 3.47266979 |
56 | renal absorption (GO:0070293) | 3.46656334 |
57 | cellular response to vitamin D (GO:0071305) | 3.46496559 |
58 | sphingosine metabolic process (GO:0006670) | 3.44352561 |
59 | endosome to melanosome transport (GO:0035646) | 3.43762232 |
60 | endosome to pigment granule transport (GO:0043485) | 3.43762232 |
61 | lysine metabolic process (GO:0006553) | 3.42733569 |
62 | lysine catabolic process (GO:0006554) | 3.42733569 |
63 | angiogenesis involved in wound healing (GO:0060055) | 3.41237638 |
64 | glutathione biosynthetic process (GO:0006750) | 3.40485351 |
65 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.35718031 |
66 | lipoxygenase pathway (GO:0019372) | 3.32152302 |
67 | detection of other organism (GO:0098543) | 3.31610953 |
68 | cellular protein complex disassembly (GO:0043624) | 3.30746075 |
69 | regulation of platelet aggregation (GO:0090330) | 3.30024956 |
70 | response to interferon-alpha (GO:0035455) | 3.25101185 |
71 | regulation of ruffle assembly (GO:1900027) | 3.25040117 |
72 | metanephric tubule development (GO:0072170) | 3.24852035 |
73 | metanephric nephron tubule development (GO:0072234) | 3.24852035 |
74 | response to thyroid hormone (GO:0097066) | 3.23918154 |
75 | response to interferon-beta (GO:0035456) | 3.23627927 |
76 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.22879567 |
77 | regulation of platelet activation (GO:0010543) | 3.22837159 |
78 | branched-chain amino acid metabolic process (GO:0009081) | 3.21958124 |
79 | fibrinolysis (GO:0042730) | 3.19765658 |
80 | diol metabolic process (GO:0034311) | 3.12888327 |
81 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.12864139 |
82 | surfactant homeostasis (GO:0043129) | 3.12285304 |
83 | carnitine metabolic process (GO:0009437) | 3.07990929 |
84 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.06710018 |
85 | maturation of SSU-rRNA (GO:0030490) | 3.06087932 |
86 | cysteine metabolic process (GO:0006534) | 3.04931411 |
87 | neutrophil activation (GO:0042119) | 3.02232445 |
88 | water homeostasis (GO:0030104) | 3.02009380 |
89 | metanephric nephron epithelium development (GO:0072243) | 2.99988100 |
90 | keratinocyte differentiation (GO:0030216) | 2.98719630 |
91 | response to phenylpropanoid (GO:0080184) | 2.97558513 |
92 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.97204807 |
93 | positive regulation of hemostasis (GO:1900048) | 2.97117619 |
94 | positive regulation of blood coagulation (GO:0030194) | 2.97117619 |
95 | negative regulation of coagulation (GO:0050819) | 2.92539251 |
96 | negative regulation of kidney development (GO:0090185) | 2.92222830 |
97 | antimicrobial humoral response (GO:0019730) | 2.91707029 |
98 | antibacterial humoral response (GO:0019731) | 2.90878203 |
99 | low-density lipoprotein particle remodeling (GO:0034374) | 2.90659005 |
100 | regulation of lipoprotein metabolic process (GO:0050746) | 2.89748757 |
101 | fucose catabolic process (GO:0019317) | 2.88821773 |
102 | L-fucose metabolic process (GO:0042354) | 2.88821773 |
103 | L-fucose catabolic process (GO:0042355) | 2.88821773 |
104 | vitamin D metabolic process (GO:0042359) | 2.88248869 |
105 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86457854 |
106 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.84848490 |
107 | negative regulation of hemostasis (GO:1900047) | 2.84566792 |
108 | negative regulation of blood coagulation (GO:0030195) | 2.84566792 |
109 | interferon-gamma secretion (GO:0072643) | 2.84519511 |
110 | metanephric epithelium development (GO:0072207) | 2.84476550 |
111 | drug catabolic process (GO:0042737) | 2.83771824 |
112 | protein complex disassembly (GO:0043241) | 2.81636787 |
113 | amino-acid betaine metabolic process (GO:0006577) | 2.78312546 |
114 | exogenous drug catabolic process (GO:0042738) | 2.77438858 |
115 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77390969 |
116 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.76899388 |
117 | glyoxylate metabolic process (GO:0046487) | 2.75971840 |
118 | fucose metabolic process (GO:0006004) | 2.75304695 |
119 | protein targeting to membrane (GO:0006612) | 2.74447771 |
120 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.74111951 |
121 | cytidine metabolic process (GO:0046087) | 2.73542183 |
122 | cytidine catabolic process (GO:0006216) | 2.73542183 |
123 | cytidine deamination (GO:0009972) | 2.73542183 |
124 | nephron tubule development (GO:0072080) | 2.72655874 |
125 | granulocyte activation (GO:0036230) | 2.72160075 |
126 | peptide biosynthetic process (GO:0043043) | 2.71798535 |
127 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.71778930 |
128 | glucosamine-containing compound catabolic process (GO:1901072) | 2.70773759 |
129 | platelet aggregation (GO:0070527) | 2.69834793 |
130 | positive regulation of coagulation (GO:0050820) | 2.69682303 |
131 | regulation of hemostasis (GO:1900046) | 2.69025819 |
132 | regulation of blood coagulation (GO:0030193) | 2.69025819 |
133 | short-chain fatty acid metabolic process (GO:0046459) | 2.68441358 |
134 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.68326285 |
135 | chemical homeostasis within a tissue (GO:0048875) | 2.68148249 |
136 | superoxide anion generation (GO:0042554) | 2.67976104 |
137 | regulation of coagulation (GO:0050818) | 2.66403615 |
138 | translational initiation (GO:0006413) | 2.66022721 |
139 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.66000471 |
140 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.64664778 |
141 | cyclooxygenase pathway (GO:0019371) | 2.63960441 |
142 | cellular glucuronidation (GO:0052695) | 2.61488322 |
143 | organ or tissue specific immune response (GO:0002251) | 2.59896171 |
144 | protein activation cascade (GO:0072376) | 2.59817087 |
145 | innate immune response in mucosa (GO:0002227) | 2.56323986 |
146 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56263473 |
147 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.55220652 |
148 | platelet degranulation (GO:0002576) | 2.54217477 |
149 | positive regulation of macrophage differentiation (GO:0045651) | 2.54185222 |
150 | negative regulation of wound healing (GO:0061045) | 2.53728443 |
151 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51686123 |
152 | glucuronate metabolic process (GO:0019585) | 2.49727224 |
153 | uronic acid metabolic process (GO:0006063) | 2.49727224 |
154 | xenobiotic catabolic process (GO:0042178) | 2.49531150 |
155 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.49327399 |
156 | acute inflammatory response (GO:0002526) | 2.47911918 |
157 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.47475920 |
158 | negative regulation of platelet activation (GO:0010544) | 2.46056315 |
159 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.45071377 |
160 | positive regulation of focal adhesion assembly (GO:0051894) | 2.43932416 |
161 | positive regulation of cell junction assembly (GO:1901890) | 2.43932416 |
162 | negative regulation of viral entry into host cell (GO:0046597) | 2.42440668 |
163 | adenosine receptor signaling pathway (GO:0001973) | 2.41403334 |
164 | positive regulation of type 2 immune response (GO:0002830) | 2.39751460 |
165 | autophagic vacuole fusion (GO:0000046) | 2.39583785 |
166 | regulation of triglyceride catabolic process (GO:0010896) | 2.39324715 |
167 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.37332483 |
168 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.36875488 |
169 | complement activation, classical pathway (GO:0006958) | 2.36073434 |
170 | mucosal immune response (GO:0002385) | 2.35237142 |
171 | regulation of regulatory T cell differentiation (GO:0045589) | 2.34501660 |
172 | regulation of protein activation cascade (GO:2000257) | 2.34387348 |
173 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.34324903 |
174 | positive regulation of tissue remodeling (GO:0034105) | 2.33776504 |
175 | positive regulation of substrate adhesion-dependent cell spreading (GO:1900026) | 2.33265980 |
176 | arginine catabolic process (GO:0006527) | 2.31694146 |
177 | positive regulation of receptor recycling (GO:0001921) | 2.29659814 |
178 | regulation of complement activation (GO:0030449) | 2.28314132 |
179 | fatty acid elongation (GO:0030497) | 2.28032125 |
180 | positive regulation of adherens junction organization (GO:1903393) | 2.27452235 |
181 | high-density lipoprotein particle remodeling (GO:0034375) | 2.27429314 |
182 | regulation of metalloenzyme activity (GO:0048552) | 2.27327705 |
183 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.26593228 |
184 | regulation of receptor recycling (GO:0001919) | 2.25907502 |
185 | regulation of guanylate cyclase activity (GO:0031282) | 2.24968159 |
186 | negative regulation of glycoprotein metabolic process (GO:1903019) | 2.24550459 |
187 | platelet activation (GO:0030168) | 2.24486715 |
188 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.24205610 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.03584834 |
2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 5.05494651 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.94727306 |
4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.83901340 |
5 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.28274075 |
6 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.04628560 |
7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.79870599 |
8 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.43739434 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.38836169 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.36180923 |
11 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.34633212 |
12 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 2.31933134 |
13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.28683325 |
14 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20477868 |
15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.04357502 |
16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.03850249 |
17 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.01084499 |
18 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98952597 |
19 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.95710129 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.92055774 |
21 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.88732628 |
22 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.87954830 |
23 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.84166658 |
24 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.80039515 |
25 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.80024673 |
26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.78409185 |
27 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.75073036 |
28 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.74323361 |
29 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74116306 |
30 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.71539990 |
31 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.71406891 |
32 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.67700774 |
33 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.67555878 |
34 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.63967230 |
35 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.60765435 |
36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.60290004 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.52194260 |
38 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51121361 |
39 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.48322194 |
40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48233308 |
41 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.43584348 |
42 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41766042 |
43 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.39918491 |
44 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39417751 |
45 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36811609 |
46 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.36246016 |
47 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.35629611 |
48 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.35629611 |
49 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.35183251 |
50 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35133283 |
51 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34027253 |
52 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32089878 |
53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.29293205 |
54 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.29287904 |
55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29080606 |
56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.28802266 |
57 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.27708023 |
58 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27259914 |
59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27089262 |
60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.26547793 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25224949 |
62 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.25187700 |
63 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.25121183 |
64 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23489948 |
65 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.22483685 |
66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21100684 |
67 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20417305 |
68 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.19804799 |
69 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16093334 |
70 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15743033 |
71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15235644 |
72 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.14826501 |
73 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.14686869 |
74 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14619759 |
75 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.12886560 |
76 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12761250 |
77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11266742 |
78 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.11127717 |
79 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08697311 |
80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.08179843 |
81 | MAF_26560356_Chip-Seq_TH1_Human | 1.08113642 |
82 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06987733 |
83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06158888 |
84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05390704 |
85 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04185450 |
86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.02883968 |
87 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02725921 |
88 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02587592 |
89 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02308083 |
90 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.01546247 |
91 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01324613 |
92 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01017165 |
93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00989220 |
94 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.00318413 |
95 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99998720 |
96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.99859845 |
97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.99859845 |
98 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99492537 |
99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99356360 |
100 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.98523744 |
101 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.97783084 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97181610 |
103 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.95252614 |
104 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.95182493 |
105 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94990555 |
106 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.94974307 |
107 | GATA3_26560356_Chip-Seq_TH2_Human | 0.94062964 |
108 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.93803613 |
109 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93401507 |
110 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.92986082 |
111 | AR_20517297_ChIP-Seq_VCAP_Human | 0.92285328 |
112 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92077391 |
113 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.91696421 |
114 | MYB_26560356_Chip-Seq_TH2_Human | 0.91611875 |
115 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91236684 |
116 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90195335 |
117 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90161739 |
118 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89702429 |
119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.89465108 |
120 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88941432 |
121 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.88464083 |
122 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.88352190 |
123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.87762638 |
124 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.87724988 |
125 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.87687019 |
126 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87334930 |
127 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.87013163 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86079634 |
129 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.85651883 |
130 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.85605579 |
131 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85133956 |
132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.84423618 |
133 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.84068970 |
134 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.83243510 |
135 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.83085552 |
136 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.82723008 |
137 | MYB_26560356_Chip-Seq_TH1_Human | 0.82394761 |
138 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.82160602 |
139 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.81539217 |
140 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80970543 |
141 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80943568 |
142 | * CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.80618722 |
143 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.80514174 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002796_impaired_skin_barrier | 4.30834421 |
2 | MP0010234_abnormal_vibrissa_follicle | 4.09813952 |
3 | MP0003941_abnormal_skin_development | 4.06362002 |
4 | MP0004043_abnormal_pH_regulation | 3.41037493 |
5 | MP0004019_abnormal_vitamin_homeostasis | 3.27771820 |
6 | MP0008004_abnormal_stomach_pH | 3.00543163 |
7 | MP0005501_abnormal_skin_physiology | 2.86273603 |
8 | MP0005360_urolithiasis | 2.84999559 |
9 | MP0001765_abnormal_ion_homeostasis | 2.77305431 |
10 | MP0009643_abnormal_urine_homeostasis | 2.53270450 |
11 | MP0003195_calcinosis | 2.49801889 |
12 | MP0002138_abnormal_hepatobiliary_system | 2.45587600 |
13 | MP0005636_abnormal_mineral_homeostasis | 2.33449568 |
14 | MP0002098_abnormal_vibrissa_morphology | 2.31990107 |
15 | MP0005083_abnormal_biliary_tract | 2.18452083 |
16 | MP0002132_abnormal_respiratory_system | 2.15240732 |
17 | MP0004381_abnormal_hair_follicle | 2.12619762 |
18 | MP0005451_abnormal_body_composition | 2.06091198 |
19 | MP0005332_abnormal_amino_acid | 2.02862183 |
20 | MP0002139_abnormal_hepatobiliary_system | 1.97869332 |
21 | MP0002136_abnormal_kidney_physiology | 1.95648949 |
22 | MP0001216_abnormal_epidermal_layer | 1.93284917 |
23 | MP0001756_abnormal_urination | 1.92907541 |
24 | MP0003303_peritoneal_inflammation | 1.88309291 |
25 | MP0004947_skin_inflammation | 1.82790164 |
26 | MP0006082_CNS_inflammation | 1.81718809 |
27 | MP0004147_increased_porphyrin_level | 1.75806503 |
28 | MP0003724_increased_susceptibility_to | 1.71871171 |
29 | MP0009379_abnormal_foot_pigmentation | 1.70311359 |
30 | MP0002060_abnormal_skin_morphology | 1.65693165 |
31 | MP0001835_abnormal_antigen_presentation | 1.64031588 |
32 | MP0000343_altered_response_to | 1.61070566 |
33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.60389976 |
34 | MP0005275_abnormal_skin_tensile | 1.56442805 |
35 | MP0003191_abnormal_cellular_cholesterol | 1.56279257 |
36 | MP0005075_abnormal_melanosome_morpholog | 1.54974261 |
37 | MP0002254_reproductive_system_inflammat | 1.54289905 |
38 | MP0003183_abnormal_peptide_metabolism | 1.53539196 |
39 | MP0005023_abnormal_wound_healing | 1.50068007 |
40 | MP0009785_altered_susceptibility_to | 1.48702129 |
41 | MP0003879_abnormal_hair_cell | 1.48429969 |
42 | MP0000377_abnormal_hair_follicle | 1.48335240 |
43 | MP0005058_abnormal_lysosome_morphology | 1.46516394 |
44 | MP0004510_myositis | 1.46341115 |
45 | MP0010771_integument_phenotype | 1.45861584 |
46 | MP0003315_abnormal_perineum_morphology | 1.44992207 |
47 | MP0000465_gastrointestinal_hemorrhage | 1.43212153 |
48 | MP0003806_abnormal_nucleotide_metabolis | 1.43109050 |
49 | MP0003453_abnormal_keratinocyte_physiol | 1.41279756 |
50 | MP0001851_eye_inflammation | 1.39945131 |
51 | MP0000678_abnormal_parathyroid_gland | 1.39648595 |
52 | MP0005174_abnormal_tail_pigmentation | 1.39547963 |
53 | MP0003828_pulmonary_edema | 1.38457714 |
54 | MP0006054_spinal_hemorrhage | 1.36357697 |
55 | MP0009840_abnormal_foam_cell | 1.34829796 |
56 | MP0000685_abnormal_immune_system | 1.33751497 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.33350121 |
58 | MP0004272_abnormal_basement_membrane | 1.33333795 |
59 | MP0005464_abnormal_platelet_physiology | 1.33262660 |
60 | MP0005166_decreased_susceptibility_to | 1.32473358 |
61 | MP0003950_abnormal_plasma_membrane | 1.30008063 |
62 | MP0001191_abnormal_skin_condition | 1.28699192 |
63 | MP0001958_emphysema | 1.28276889 |
64 | MP0003186_abnormal_redox_activity | 1.28115105 |
65 | MP0002419_abnormal_innate_immunity | 1.27171743 |
66 | MP0002009_preneoplasia | 1.26719663 |
67 | MP0002166_altered_tumor_susceptibility | 1.26538935 |
68 | MP0001664_abnormal_digestion | 1.23504120 |
69 | MP0005084_abnormal_gallbladder_morpholo | 1.22829732 |
70 | MP0010329_abnormal_lipoprotein_level | 1.22361499 |
71 | MP0003436_decreased_susceptibility_to | 1.22156678 |
72 | MP0001533_abnormal_skeleton_physiology | 1.21262902 |
73 | MP0005377_hearing/vestibular/ear_phenot | 1.20950355 |
74 | MP0003878_abnormal_ear_physiology | 1.20950355 |
75 | MP0001663_abnormal_digestive_system | 1.20114532 |
76 | MP0000249_abnormal_blood_vessel | 1.19842797 |
77 | MP0005025_abnormal_response_to | 1.19263790 |
78 | MP0003868_abnormal_feces_composition | 1.18595214 |
79 | MP0004264_abnormal_extraembryonic_tissu | 1.16067409 |
80 | MP0009931_abnormal_skin_appearance | 1.15679335 |
81 | MP0010155_abnormal_intestine_physiology | 1.15595048 |
82 | MP0001800_abnormal_humoral_immune | 1.14629073 |
83 | MP0003866_abnormal_defecation | 1.14460232 |
84 | MP0000230_abnormal_systemic_arterial | 1.13226173 |
85 | MP0008872_abnormal_physiological_respon | 1.12348204 |
86 | MP0000858_altered_metastatic_potential | 1.11947657 |
87 | MP0010386_abnormal_urinary_bladder | 1.11308751 |
88 | MP0005671_abnormal_response_to | 1.10204538 |
89 | MP0010678_abnormal_skin_adnexa | 1.09846872 |
90 | MP0003566_abnormal_cell_adhesion | 1.09395158 |
91 | MP0000538_abnormal_urinary_bladder | 1.08694792 |
92 | MP0004782_abnormal_surfactant_physiolog | 1.08636033 |
93 | MP0002452_abnormal_antigen_presenting | 1.08164115 |
94 | MP0000367_abnormal_coat/_hair | 1.07208167 |
95 | MP0009764_decreased_sensitivity_to | 1.06491731 |
96 | MP0001666_abnormal_nutrient_absorption | 1.06365304 |
97 | MP0005085_abnormal_gallbladder_physiolo | 1.05966313 |
98 | MP0002006_tumorigenesis | 1.04704456 |
99 | MP0005164_abnormal_response_to | 1.04531766 |
100 | MP0001545_abnormal_hematopoietic_system | 1.04257519 |
101 | MP0005397_hematopoietic_system_phenotyp | 1.04257519 |
102 | MP0003300_gastrointestinal_ulcer | 1.02731452 |
103 | MP0009763_increased_sensitivity_to | 1.01895243 |
104 | MP0003638_abnormal_response/metabolism_ | 1.01816273 |
105 | MP0005365_abnormal_bile_salt | 1.00125386 |
106 | MP0009333_abnormal_splenocyte_physiolog | 0.98677320 |
107 | MP0002118_abnormal_lipid_homeostasis | 0.97268828 |
108 | MP0008874_decreased_physiological_sensi | 0.97139234 |
109 | MP0002877_abnormal_melanocyte_morpholog | 0.95361598 |
110 | MP0001790_abnormal_immune_system | 0.94198519 |
111 | MP0005387_immune_system_phenotype | 0.94198519 |
112 | MP0005220_abnormal_exocrine_pancreas | 0.93083499 |
113 | MP0005165_increased_susceptibility_to | 0.90939596 |
114 | MP0001845_abnormal_inflammatory_respons | 0.90280624 |
115 | MP0002998_abnormal_bone_remodeling | 0.89247679 |
116 | MP0001819_abnormal_immune_cell | 0.87882625 |
117 | MP0003656_abnormal_erythrocyte_physiolo | 0.87620190 |
118 | MP0003252_abnormal_bile_duct | 0.86761555 |
119 | MP0002420_abnormal_adaptive_immunity | 0.86526416 |
120 | MP0009642_abnormal_blood_homeostasis | 0.86132552 |
121 | MP0003943_abnormal_hepatobiliary_system | 0.85866509 |
122 | MP0005000_abnormal_immune_tolerance | 0.84958501 |
123 | MP0000490_abnormal_crypts_of | 0.84855520 |
124 | MP0004808_abnormal_hematopoietic_stem | 0.83462149 |
125 | MP0008260_abnormal_autophagy | 0.83366012 |
126 | MP0003075_altered_response_to | 0.83272705 |
127 | MP0002928_abnormal_bile_duct | 0.81803039 |
128 | MP0008469_abnormal_protein_level | 0.81480517 |
129 | MP0002135_abnormal_kidney_morphology | 0.80774004 |
130 | MP0000579_abnormal_nail_morphology | 0.80679756 |
131 | MP0001853_heart_inflammation | 0.80297981 |
132 | MP0005410_abnormal_fertilization | 0.79080631 |
133 | MP0002095_abnormal_skin_pigmentation | 0.78701409 |
134 | MP0000566_synostosis | 0.77498450 |
135 | MP0009697_abnormal_copulation | 0.76471948 |
136 | MP0004883_abnormal_blood_vessel | 0.76464142 |
137 | MP0000647_abnormal_sebaceous_gland | 0.74796852 |
138 | MP0003011_delayed_dark_adaptation | 0.74793100 |
139 | MP0002723_abnormal_immune_serum | 0.73976290 |
140 | MP0001873_stomach_inflammation | 0.73522452 |
141 | MP0000383_abnormal_hair_follicle | 0.73102844 |
142 | MP0005381_digestive/alimentary_phenotyp | 0.72232575 |
143 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71361477 |
144 | MP0003763_abnormal_thymus_physiology | 0.71161558 |
145 | MP0001764_abnormal_homeostasis | 0.71149349 |
146 | MP0002876_abnormal_thyroid_physiology | 0.71027230 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Menorrhagia (HP:0000132) | 6.66686231 |
2 | Purpura (HP:0000979) | 6.07630018 |
3 | Increased mean platelet volume (HP:0011877) | 5.81202211 |
4 | Hypokalemic alkalosis (HP:0001949) | 5.74529804 |
5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.74419597 |
6 | Metabolic alkalosis (HP:0200114) | 5.63544854 |
7 | Abnormal platelet volume (HP:0011876) | 5.63403836 |
8 | Abnormality of chloride homeostasis (HP:0011422) | 5.30695237 |
9 | Increased circulating renin level (HP:0000848) | 5.28975496 |
10 | Hypomagnesemia (HP:0002917) | 5.19827708 |
11 | Epistaxis (HP:0000421) | 5.03174981 |
12 | Gout (HP:0001997) | 4.91553627 |
13 | Polyuria (HP:0000103) | 4.80898783 |
14 | Gingival bleeding (HP:0000225) | 4.74188465 |
15 | Abnormality of magnesium homeostasis (HP:0004921) | 4.71246200 |
16 | Abnormal urine output (HP:0012590) | 4.44756540 |
17 | Abnormality of renal excretion (HP:0011036) | 4.38327488 |
18 | Generalized aminoaciduria (HP:0002909) | 4.33141256 |
19 | Proximal tubulopathy (HP:0000114) | 4.18236378 |
20 | Tetany (HP:0001281) | 4.15132821 |
21 | Hyperlipoproteinemia (HP:0010980) | 4.14179406 |
22 | Hyperaldosteronism (HP:0000859) | 3.99833621 |
23 | Abnormality of renin-angiotensin system (HP:0000847) | 3.95114595 |
24 | Abnormal drinking behavior (HP:0030082) | 3.90950698 |
25 | Polydipsia (HP:0001959) | 3.90950698 |
26 | Alkalosis (HP:0001948) | 3.82256512 |
27 | Renal salt wasting (HP:0000127) | 3.76636796 |
28 | Reticulocytopenia (HP:0001896) | 3.48562750 |
29 | Increased purine levels (HP:0004368) | 3.37111564 |
30 | Hyperuricemia (HP:0002149) | 3.37111564 |
31 | Vacuolated lymphocytes (HP:0001922) | 3.35215120 |
32 | Abnormality of macrophages (HP:0004311) | 3.30493569 |
33 | Poikilocytosis (HP:0004447) | 3.18589250 |
34 | Hypokalemia (HP:0002900) | 3.18213348 |
35 | Glycosuria (HP:0003076) | 3.17211027 |
36 | Abnormality of urine glucose concentration (HP:0011016) | 3.17211027 |
37 | Abnormality of purine metabolism (HP:0004352) | 3.15719791 |
38 | Acanthocytosis (HP:0001927) | 3.13112661 |
39 | Renal tubular acidosis (HP:0001947) | 3.10311332 |
40 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.01451772 |
41 | Abnormality of the common coagulation pathway (HP:0010990) | 2.99010370 |
42 | Increased IgE level (HP:0003212) | 2.98364607 |
43 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.96910660 |
44 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.96764642 |
45 | Dehydration (HP:0001944) | 2.87964227 |
46 | Spontaneous hematomas (HP:0007420) | 2.85131176 |
47 | Hyperphosphaturia (HP:0003109) | 2.83673722 |
48 | Malnutrition (HP:0004395) | 2.80464764 |
49 | Erythema (HP:0010783) | 2.79655266 |
50 | Eczematoid dermatitis (HP:0000976) | 2.75743043 |
51 | Hypotrichosis (HP:0001006) | 2.75228936 |
52 | Systemic lupus erythematosus (HP:0002725) | 2.73106518 |
53 | Hyperglycinuria (HP:0003108) | 2.71357213 |
54 | Petechiae (HP:0000967) | 2.70603632 |
55 | Abnormal number of erythroid precursors (HP:0012131) | 2.68952303 |
56 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.68010647 |
57 | Hypercalciuria (HP:0002150) | 2.65631403 |
58 | Ileus (HP:0002595) | 2.63157037 |
59 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.60674207 |
60 | Lip pit (HP:0100267) | 2.60575812 |
61 | Abnormal pupillary function (HP:0007686) | 2.60532536 |
62 | Muscle fiber splitting (HP:0003555) | 2.60301418 |
63 | Joint hemorrhage (HP:0005261) | 2.57704938 |
64 | Dyschromatopsia (HP:0007641) | 2.57336611 |
65 | Paralysis (HP:0003470) | 2.57170968 |
66 | Xanthomatosis (HP:0000991) | 2.55806372 |
67 | Abnormality of potassium homeostasis (HP:0011042) | 2.54595225 |
68 | Thrombocytosis (HP:0001894) | 2.54355911 |
69 | Abnormal urine phosphate concentration (HP:0012599) | 2.53583161 |
70 | Bruising susceptibility (HP:0000978) | 2.51262363 |
71 | Glomerulonephritis (HP:0000099) | 2.50448494 |
72 | Joint swelling (HP:0001386) | 2.46861949 |
73 | Abnormality of iron homeostasis (HP:0011031) | 2.40324720 |
74 | Woolly hair (HP:0002224) | 2.37065689 |
75 | Abnormality of renal resorption (HP:0011038) | 2.35685224 |
76 | Ketoacidosis (HP:0001993) | 2.34346941 |
77 | Hepatosplenomegaly (HP:0001433) | 2.33478579 |
78 | IgM deficiency (HP:0002850) | 2.32182839 |
79 | Hypochromic microcytic anemia (HP:0004840) | 2.31752075 |
80 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.26521274 |
81 | Increased serum ferritin (HP:0003281) | 2.25321379 |
82 | Delayed epiphyseal ossification (HP:0002663) | 2.25272779 |
83 | Polycythemia (HP:0001901) | 2.24436394 |
84 | Abnormality of nucleobase metabolism (HP:0010932) | 2.23781196 |
85 | Alopecia of scalp (HP:0002293) | 2.23505104 |
86 | Increased IgM level (HP:0003496) | 2.21863981 |
87 | Nephrolithiasis (HP:0000787) | 2.20718265 |
88 | Abnormality of proline metabolism (HP:0010907) | 2.20532680 |
89 | Hydroxyprolinuria (HP:0003080) | 2.20532680 |
90 | Macrocytic anemia (HP:0001972) | 2.20195160 |
91 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.19660496 |
92 | Renal tubular dysfunction (HP:0000124) | 2.18226331 |
93 | Hyponatremia (HP:0002902) | 2.17806561 |
94 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.17769371 |
95 | Adrenal overactivity (HP:0002717) | 2.13867732 |
96 | Natal tooth (HP:0000695) | 2.12898289 |
97 | Onycholysis (HP:0001806) | 2.12306738 |
98 | Mitral stenosis (HP:0001718) | 2.11683184 |
99 | Congenital sensorineural hearing impairment (HP:0008527) | 2.11413993 |
100 | Decreased circulating renin level (HP:0003351) | 2.11223841 |
101 | Conjugated hyperbilirubinemia (HP:0002908) | 2.10819999 |
102 | Nephritis (HP:0000123) | 2.09613514 |
103 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09526462 |
104 | Abnormal platelet function (HP:0011869) | 2.06593673 |
105 | Impaired platelet aggregation (HP:0003540) | 2.06593673 |
106 | Autoimmune hemolytic anemia (HP:0001890) | 2.06571503 |
107 | Hypophosphatemia (HP:0002148) | 2.05896275 |
108 | Rickets (HP:0002748) | 2.04883172 |
109 | Exocrine pancreatic insufficiency (HP:0001738) | 2.04459169 |
110 | Conjunctival telangiectasia (HP:0000524) | 2.03267837 |
111 | Glomerulosclerosis (HP:0000096) | 2.02744514 |
112 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.00211895 |
113 | Nephrocalcinosis (HP:0000121) | 1.99475566 |
114 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.98945393 |
115 | Abnormality of glycine metabolism (HP:0010895) | 1.98945393 |
116 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.98685910 |
117 | Advanced eruption of teeth (HP:0006288) | 1.97831819 |
118 | Cholecystitis (HP:0001082) | 1.97547793 |
119 | Abnormal gallbladder physiology (HP:0012438) | 1.97547793 |
120 | Hyporeflexia of lower limbs (HP:0002600) | 1.96828032 |
121 | Abnormality of sodium homeostasis (HP:0010931) | 1.95974958 |
122 | Prolonged bleeding time (HP:0003010) | 1.94810739 |
123 | Focal segmental glomerulosclerosis (HP:0000097) | 1.93890744 |
124 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93369247 |
125 | Cardiovascular calcification (HP:0011915) | 1.93214133 |
126 | Stomatitis (HP:0010280) | 1.91680738 |
127 | Ketosis (HP:0001946) | 1.91373889 |
128 | Complement deficiency (HP:0004431) | 1.90809253 |
129 | Parakeratosis (HP:0001036) | 1.90555052 |
130 | Thin bony cortex (HP:0002753) | 1.88479531 |
131 | Widely patent fontanelles and sutures (HP:0004492) | 1.87814124 |
132 | Increased density of long bones (HP:0006392) | 1.87797016 |
133 | Hypochromic anemia (HP:0001931) | 1.84469994 |
134 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.84111270 |
135 | Urticaria (HP:0001025) | 1.83461195 |
136 | Dry hair (HP:0011359) | 1.82945657 |
137 | Microcytic anemia (HP:0001935) | 1.82223874 |
138 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.81389537 |
139 | Dicarboxylic aciduria (HP:0003215) | 1.81389537 |
140 | Gangrene (HP:0100758) | 1.80773580 |
141 | Anhidrosis (HP:0000970) | 1.80533442 |
142 | Dysostosis multiplex (HP:0000943) | 1.80120150 |
143 | Hyperparathyroidism (HP:0000843) | 1.78772596 |
144 | Abnormality of complement system (HP:0005339) | 1.78209919 |
145 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.78187341 |
146 | Pallor (HP:0000980) | 1.78118889 |
147 | Abnormality of secondary sexual hair (HP:0009888) | 1.75876502 |
148 | Abnormality of the axillary hair (HP:0100134) | 1.75876502 |
149 | Deep venous thrombosis (HP:0002625) | 1.75683765 |
150 | Hypoplasia of the uterus (HP:0000013) | 1.74509725 |
151 | Corneal erosion (HP:0200020) | 1.73043585 |
152 | Pili torti (HP:0003777) | 1.73030587 |
153 | Interstitial pulmonary disease (HP:0006530) | 1.72478694 |
154 | Abnormality of the nasal mucosa (HP:0000433) | 1.72144367 |
155 | Delayed CNS myelination (HP:0002188) | 1.72002266 |
156 | Abnormality of nail color (HP:0100643) | 1.70720235 |
157 | Vascular calcification (HP:0004934) | 1.69507838 |
158 | Enlarged epiphyses (HP:0010580) | 1.69452551 |
159 | Obstructive lung disease (HP:0006536) | 1.69323167 |
160 | Chronic obstructive pulmonary disease (HP:0006510) | 1.69323167 |
161 | Abnormality of the costochondral junction (HP:0000919) | 1.69290542 |
162 | Plantar hyperkeratosis (HP:0007556) | 1.68041438 |
163 | Palmoplantar hyperkeratosis (HP:0000972) | 1.67774560 |
164 | Hemorrhage of the eye (HP:0011885) | 1.65439257 |
165 | Recurrent bacterial skin infections (HP:0005406) | 1.65331430 |
166 | Tetraparesis (HP:0002273) | 1.62662794 |
167 | Recurrent abscess formation (HP:0002722) | 1.62427477 |
168 | Nasal polyposis (HP:0100582) | 1.61842262 |
169 | Pulmonary embolism (HP:0002204) | 1.61758875 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WNK4 | 4.83420498 |
2 | WNK3 | 4.40760934 |
3 | OXSR1 | 3.80752204 |
4 | LMTK2 | 3.28213917 |
5 | MST4 | 3.00479205 |
6 | BMX | 2.97176018 |
7 | NME2 | 2.78833912 |
8 | SIK3 | 2.39225687 |
9 | TIE1 | 2.36948309 |
10 | BCKDK | 2.36426485 |
11 | MST1R | 2.21730301 |
12 | TAOK3 | 2.19502378 |
13 | TGFBR2 | 2.18537316 |
14 | MUSK | 2.07925474 |
15 | TGFBR1 | 1.99174427 |
16 | MAP3K3 | 1.97044691 |
17 | GRK6 | 1.95071036 |
18 | EIF2AK1 | 1.87785137 |
19 | MAPKAPK3 | 1.86584245 |
20 | BMPR2 | 1.81809360 |
21 | BTK | 1.71983056 |
22 | MAPK15 | 1.60079322 |
23 | LRRK2 | 1.58947138 |
24 | STK39 | 1.56175549 |
25 | RPS6KB2 | 1.52478125 |
26 | EPHB2 | 1.52315874 |
27 | PIM2 | 1.52178952 |
28 | JAK3 | 1.52041120 |
29 | MAP3K12 | 1.51737648 |
30 | MAP3K14 | 1.50405453 |
31 | CSF1R | 1.49147967 |
32 | IKBKE | 1.46417734 |
33 | MAP3K2 | 1.45916724 |
34 | PTK2B | 1.45664005 |
35 | IKBKB | 1.44136867 |
36 | BCR | 1.38308016 |
37 | MET | 1.33464130 |
38 | ERN1 | 1.29437514 |
39 | IRAK3 | 1.25742485 |
40 | TBK1 | 1.25396427 |
41 | ILK | 1.21396601 |
42 | MATK | 1.17758869 |
43 | FGR | 1.17732232 |
44 | GRK5 | 1.17150027 |
45 | MAP2K3 | 1.15509475 |
46 | ARAF | 1.14394369 |
47 | CDK19 | 1.13507843 |
48 | DYRK3 | 1.13139199 |
49 | MAPKAPK5 | 1.12582702 |
50 | TRPM7 | 1.07899458 |
51 | TEC | 1.07434185 |
52 | MAP4K1 | 1.07063490 |
53 | KIT | 1.06893128 |
54 | PIK3CG | 1.06839059 |
55 | TAOK1 | 1.02394559 |
56 | MAP2K6 | 1.01014564 |
57 | HCK | 1.00438099 |
58 | SYK | 0.99761858 |
59 | FGFR4 | 0.97272994 |
60 | TAOK2 | 0.95195004 |
61 | ACVR1B | 0.94300724 |
62 | EEF2K | 0.94160023 |
63 | INSRR | 0.93243253 |
64 | PIK3CA | 0.92023587 |
65 | TRIM28 | 0.91623968 |
66 | STK16 | 0.91598057 |
67 | DYRK1B | 0.89447569 |
68 | ZAP70 | 0.89174514 |
69 | MYLK | 0.87388000 |
70 | ADRBK1 | 0.85849957 |
71 | HIPK2 | 0.85500350 |
72 | BLK | 0.83904953 |
73 | PIM1 | 0.83855884 |
74 | MAP2K2 | 0.82798741 |
75 | STK10 | 0.81856102 |
76 | STK3 | 0.81638886 |
77 | TNIK | 0.78197730 |
78 | PASK | 0.77048197 |
79 | FER | 0.76692902 |
80 | GRK1 | 0.76622495 |
81 | PKN1 | 0.76226114 |
82 | CAMKK2 | 0.75933598 |
83 | TYK2 | 0.74235301 |
84 | TNK2 | 0.73586715 |
85 | CHUK | 0.71644661 |
86 | CSK | 0.71288507 |
87 | PAK1 | 0.69776889 |
88 | PRKCQ | 0.68742102 |
89 | DAPK3 | 0.67037622 |
90 | PTK2 | 0.64888125 |
91 | MAP3K6 | 0.64502292 |
92 | PRKG2 | 0.63598868 |
93 | RIPK4 | 0.63461705 |
94 | PTK6 | 0.61509292 |
95 | MAP3K5 | 0.60826236 |
96 | ERBB3 | 0.60617790 |
97 | PDK1 | 0.59375498 |
98 | PDPK1 | 0.59241909 |
99 | MAP3K11 | 0.57885386 |
100 | ITK | 0.57590215 |
101 | PRKD2 | 0.55993750 |
102 | RPS6KA4 | 0.54541086 |
103 | MAP2K1 | 0.54261912 |
104 | JAK1 | 0.54260582 |
105 | IRAK1 | 0.52544813 |
106 | STK38L | 0.52342020 |
107 | NLK | 0.52187912 |
108 | RIPK1 | 0.50538240 |
109 | STK24 | 0.49641408 |
110 | ERBB2 | 0.49406735 |
111 | STK38 | 0.48411586 |
112 | EPHA3 | 0.48239067 |
113 | PDK4 | 0.47931684 |
114 | PDK3 | 0.47931684 |
115 | ROCK1 | 0.47105204 |
116 | PINK1 | 0.46718685 |
117 | JAK2 | 0.46449503 |
118 | MAPK11 | 0.46429337 |
119 | MAP3K7 | 0.45002740 |
120 | KSR1 | 0.44755903 |
121 | PRKACG | 0.44166538 |
122 | EPHB1 | 0.43735268 |
123 | MAP3K1 | 0.43132367 |
124 | PRKD1 | 0.42958663 |
125 | GRK7 | 0.42556911 |
126 | MAP3K13 | 0.42275091 |
127 | LYN | 0.40190881 |
128 | RET | 0.39832750 |
129 | IRAK4 | 0.39826739 |
130 | RPS6KA5 | 0.39381129 |
131 | PRKCD | 0.39212794 |
132 | DAPK1 | 0.38665600 |
133 | FLT3 | 0.38619898 |
134 | SIK1 | 0.38587863 |
135 | FES | 0.37750055 |
136 | EPHA2 | 0.37632401 |
137 | PDK2 | 0.37360534 |
138 | CDK8 | 0.36898463 |
139 | PRKCI | 0.36736616 |
140 | RPS6KA1 | 0.34397597 |
141 | TXK | 0.33870490 |
142 | LCK | 0.33870178 |
143 | CAMK1 | 0.33639576 |
144 | NEK9 | 0.32417907 |
145 | FGFR3 | 0.32109567 |
146 | ADRBK2 | 0.31981112 |
147 | MAPKAPK2 | 0.31636926 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.06822407 |
2 | Ribosome_Homo sapiens_hsa03010 | 3.82233734 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.36512656 |
4 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.84535298 |
5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.80032612 |
6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.55245895 |
7 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.46842393 |
8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.45388913 |
9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.31105550 |
10 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.29784673 |
11 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.19276455 |
12 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.16600983 |
13 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.13314357 |
14 | Peroxisome_Homo sapiens_hsa04146 | 2.07635332 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.02455603 |
16 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.99174966 |
17 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.95622433 |
18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95040192 |
19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.91615074 |
20 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.91150830 |
21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.89938333 |
22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.83333244 |
23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.83102616 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.75290079 |
25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.64762837 |
26 | Histidine metabolism_Homo sapiens_hsa00340 | 1.56071384 |
27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.53767261 |
28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51316999 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.44301601 |
30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.44242634 |
31 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42166920 |
32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41696674 |
33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.39990458 |
34 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.35969490 |
35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32125467 |
36 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.26047619 |
37 | Mineral absorption_Homo sapiens_hsa04978 | 1.25313876 |
38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.24499184 |
39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23214695 |
40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22877433 |
41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.22426972 |
42 | Malaria_Homo sapiens_hsa05144 | 1.21217442 |
43 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18134825 |
44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12303715 |
45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12058525 |
46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.11176903 |
47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.10165365 |
48 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09727255 |
49 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.09474438 |
50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.09087538 |
51 | ABC transporters_Homo sapiens_hsa02010 | 1.06671245 |
52 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06000586 |
53 | Lysosome_Homo sapiens_hsa04142 | 1.03269436 |
54 | Asthma_Homo sapiens_hsa05310 | 1.02623301 |
55 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.02314960 |
56 | Protein export_Homo sapiens_hsa03060 | 1.00709680 |
57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.00211311 |
58 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89535502 |
59 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86633672 |
60 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.86615791 |
61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.85360936 |
62 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.84231375 |
63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84212624 |
64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83130506 |
65 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.77051532 |
66 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.75300682 |
67 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75265361 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.75153469 |
69 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.74774137 |
70 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.73259241 |
71 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72950132 |
72 | Salmonella infection_Homo sapiens_hsa05132 | 0.72467819 |
73 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.72082311 |
74 | Amoebiasis_Homo sapiens_hsa05146 | 0.71923478 |
75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.71638251 |
76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71553238 |
77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.71506268 |
78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.69757344 |
79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68452826 |
80 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.68332209 |
81 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67307812 |
82 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.67137510 |
83 | Leishmaniasis_Homo sapiens_hsa05140 | 0.66531450 |
84 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66163008 |
85 | Hepatitis C_Homo sapiens_hsa05160 | 0.65844216 |
86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65459434 |
87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64121970 |
88 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.63157244 |
89 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62585266 |
90 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62386688 |
91 | Allograft rejection_Homo sapiens_hsa05330 | 0.61054342 |
92 | Shigellosis_Homo sapiens_hsa05131 | 0.59967643 |
93 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.59460460 |
94 | Bile secretion_Homo sapiens_hsa04976 | 0.57832024 |
95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.57798142 |
96 | Pertussis_Homo sapiens_hsa05133 | 0.57356553 |
97 | Endocytosis_Homo sapiens_hsa04144 | 0.56155749 |
98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54516675 |
99 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.54258729 |
100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52968316 |
101 | Phagosome_Homo sapiens_hsa04145 | 0.52951239 |
102 | Platelet activation_Homo sapiens_hsa04611 | 0.52820161 |
103 | Legionellosis_Homo sapiens_hsa05134 | 0.52546290 |
104 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52340940 |
105 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52026551 |
106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51623245 |
107 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51501621 |
108 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.51297291 |
109 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.50807026 |
110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49437717 |
111 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49399785 |
112 | Tuberculosis_Homo sapiens_hsa05152 | 0.48656323 |
113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.48443937 |
114 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47551441 |
115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.47272679 |
116 | Measles_Homo sapiens_hsa05162 | 0.47054363 |
117 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46593768 |
118 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45694865 |
119 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.45081724 |
120 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.45046199 |
121 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.45025913 |
122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43261581 |
123 | Influenza A_Homo sapiens_hsa05164 | 0.42629914 |
124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42484858 |
125 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.41409484 |
126 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.40951485 |
127 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.39739998 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38283727 |
129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38174802 |
130 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.37599625 |
131 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36521996 |
132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.35706602 |
133 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35222157 |
134 | Viral myocarditis_Homo sapiens_hsa05416 | 0.34312437 |
135 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.33479149 |
136 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.31541872 |
137 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.31377707 |
138 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.31188826 |